Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Jan 2021
Historique:
received: 30 12 2020
revised: 15 01 2021
accepted: 16 01 2021
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 7 9 2021
Statut: epublish

Résumé

Serotonin receptors are extensively examined by academic and industrial researchers, due to their vital roles, which they play in the organism and constituting therefore important drug targets. Up to very recently, it was assumed that the basic nitrogen in compound structure is a necessary component to make it active within this receptor system. Such nitrogen interacts in its protonated form with the aspartic acid from the third transmembrane helix (D3x32) forming a hydrogen bond tightly fitting the ligand in the protein binding site. However, there are several recent studies that report strong serotonin receptor affinity also for compounds without a basic moiety in their structures. In the study, we carried out a comprehensive in silico analysis of the low-basicity phenomenon of the selected serotonin receptor ligands. We focused on the crystallized representatives of the proteins of 5-HT

Identifiants

pubmed: 33494248
pii: ijms22031035
doi: 10.3390/ijms22031035
pmc: PMC7864501
pii:
doi:

Substances chimiques

Ligands 0
Receptors, Serotonin, 5-HT2 0
Serotonin 5-HT2 Receptor Agonists 0
Serotonin 5-HT2 Receptor Antagonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Narodowe Centrum Nauki
ID : SONATINA 2018/28/C/NZ7/00145

Références

J Med Chem. 1998 Dec 3;41(25):4995-5001
pubmed: 9836617
J Nat Prod. 2002 Apr;65(4):476-80
pubmed: 11975483
Bioorg Med Chem. 2011 Oct 1;19(19):5756-62
pubmed: 21907583
Am J Physiol Regul Integr Comp Physiol. 2018 Feb 1;314(2):R313-R321
pubmed: 29046318
Bioorg Med Chem Lett. 2005 Jun 2;15(11):2898-901
pubmed: 15911276
Science. 2013 May 3;340(6132):615-9
pubmed: 23519215
Front Behav Neurosci. 2015 May 08;9:92
pubmed: 26005408
J Med Chem. 2007 Aug 23;50(17):4135-46
pubmed: 17672446
Cell. 2018 Feb 8;172(4):719-730.e14
pubmed: 29398112
J Med Chem. 2002 Jan 17;45(2):492-503
pubmed: 11784153
Brain Res. 2016 Aug 15;1645:46-9
pubmed: 26740406
Mar Drugs. 2017 Aug 09;15(8):
pubmed: 28792478
ACS Med Chem Lett. 2017 Mar 27;8(4):390-394
pubmed: 28435524
Neuropsychiatr Dis Treat. 2020 Oct 28;16:2499-2509
pubmed: 33149591
Bioorg Med Chem Lett. 2000 Aug 21;10(16):1867-70
pubmed: 10969987
J Neurochem. 2005 Jan;92(2):375-87
pubmed: 15663485
Ther Adv Psychopharmacol. 2019 Mar 11;9:2045125318818814
pubmed: 30886699
Bioorg Med Chem. 2013 Nov 15;21(22):7083-90
pubmed: 24084296
J Med Chem. 1997 Oct 24;40(22):3494-6
pubmed: 9357513
Bioorg Med Chem Lett. 2005 Oct 15;15(20):4555-9
pubmed: 16061378
Bioorg Med Chem Lett. 2000 Aug 21;10(16):1863-6
pubmed: 10969986
Bioorg Med Chem Lett. 2005 Aug 15;15(16):3665-9
pubmed: 15993598
Pharmacol Ther. 2013 Jan;137(1):119-31
pubmed: 23022360
Neuropharmacology. 2020 Nov 15;179:108233
pubmed: 32805212
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Med Chem. 1995 Jul 7;38(14):2524-30
pubmed: 7629791
Science. 2013 May 3;340(6132):610-4
pubmed: 23519210
Antiinflamm Antiallergy Agents Med Chem. 2020;19(4):342-369
pubmed: 31518227
J Med Chem. 1993 Apr 16;36(8):1104-7
pubmed: 8478907
J Med Chem. 2009 Apr 9;52(7):1885-902
pubmed: 19284718
Br J Pharmacol. 1994 Mar;111(3):797-802
pubmed: 7912626
Eur J Med Chem. 2016 Feb 15;109:360-70
pubmed: 26820449
J Cheminform. 2015 May 20;7:20
pubmed: 26052348
Eur Neuropsychopharmacol. 2016 Aug;26(8):1327-37
pubmed: 27216487
J Med Chem. 2005 Jan 27;48(2):353-6
pubmed: 15658848
J Biol Chem. 2002 May 10;277(19):17170-8
pubmed: 11859080
Eur J Med Chem. 2012 Mar;49:310-23
pubmed: 22301214
Science. 2013 Dec 20;342(6165):1521-4
pubmed: 24357322
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3708-12
pubmed: 20493697
Physiol Rev. 2012 Jul;92(3):1393-478
pubmed: 22988594
Chem Rev. 2008 May;108(5):1614-41
pubmed: 18476671
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7
pubmed: 21948594
J Med Chem. 2011 May 26;54(10):3581-94
pubmed: 21495689
J Med Chem. 2010 Aug 12;53(15):5696-706
pubmed: 20684606
Bioorg Med Chem Lett. 2010 Sep 15;20(18):5488-90
pubmed: 20692833
Pharmacol Res. 2019 Feb;140:100-114
pubmed: 29953943
Bioorg Med Chem Lett. 2011 Nov 15;21(22):6816-9
pubmed: 21974955
J Med Chem. 2010 Mar 11;53(5):1923-36
pubmed: 20143782
Bioorg Med Chem Lett. 2007 May 1;17(9):2643-8
pubmed: 17314044
Curr Biol. 1995 Sep 1;5(9):997-9
pubmed: 8542294
J Med Chem. 2010 Jul 22;53(14):5186-96
pubmed: 20560595
J Med Chem. 2017 Apr 13;60(7):3109-3123
pubmed: 28319392
Curr Med Chem. 2001 Jul;8(9):999-1034
pubmed: 11472239
Bioorg Med Chem Lett. 2005 Nov 15;15(22):4989-93
pubmed: 16168649
Bioorg Med Chem. 2010 Jul 1;18(13):4783-92
pubmed: 20570529
J Med Chem. 2012 Jun 28;55(12):5749-59
pubmed: 22694093
J Med Chem. 1995 Mar 17;38(6):855-7
pubmed: 7699699
J Med Chem. 2000 Mar 23;43(6):1123-34
pubmed: 10737744
J Med Chem. 2016 Dec 22;59(24):11006-11026
pubmed: 27933810
J Med Chem. 2004 Jan 15;47(2):337-44
pubmed: 14711306
Bioorg Med Chem Lett. 2006 Jun 15;16(12):3201-4
pubmed: 16632354
Bioorg Med Chem Lett. 2014 Oct 1;24(19):4754-4758
pubmed: 25193229
Bioorg Med Chem Lett. 2001 Jul 23;11(14):1907-10
pubmed: 11459658
J Med Chem. 1986 Nov;29(11):2415-8
pubmed: 3783602
Eur J Med Chem. 2020 Jan 1;185:111857
pubmed: 31734022
Nat Struct Mol Biol. 2019 Feb;26(2):121-128
pubmed: 30723326
J Med Chem. 1998 May 7;41(10):1598-612
pubmed: 9572885
Transl Neurosci. 2016 May 9;7(1):35-49
pubmed: 28123820
J Neurochem. 1998 Nov;71(5):2169-77
pubmed: 9798944
J Chem Inf Model. 2010 May 24;50(5):771-84
pubmed: 20450209
Int J Mol Sci. 2020 May 15;21(10):
pubmed: 32429111
Bioorg Med Chem Lett. 2017 Feb 1;27(3):626-631
pubmed: 27993519
Exp Brain Res. 2014 Mar;232(3):723-38
pubmed: 24430027
Protein Eng. 1997 Jun;10(6):737-41
pubmed: 9278289

Auteurs

Sabina Podlewska (S)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Kraków, Poland.
Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.

Ryszard Bugno (R)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.

Enza Lacivita (E)

Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", via E. Orabona 4, 70125 Bari, Italy.

Marcello Leopoldo (M)

Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", via E. Orabona 4, 70125 Bari, Italy.

Andrzej J Bojarski (AJ)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.

Jadwiga Handzlik (J)

Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH